Viral Clearance Using Traditional, Well-Understood Unit Operations Session 1.2: Virus-Retentive Filtration

References

1. 1.↵
   1. Chen D.,
   2. Chen Q.

   Viral Clearance of Traditional Unit Operations: Virus-Retentive Filtration. PDA J. Pharm. Sci. Technol. 2015, 69 (1-2), 142–153.

   OpenUrlFREE Full Text
2. 2.↵
   1. Miesegaes G.,
   2. Lute S.,
   3. Brorson K.

   Analysis of Viral Clearance Unit Operations for Monoclonal Antibodies. Biotechnol. Bioeng. 2010, 106 (2), 238–246.

   OpenUrlPubMed
3. 3.↵
   1. Chen D.

   Viral Clearance Using Traditional, Well-Understood Unit Operations (Session 1): Virus-Retentive Filtration. PDA J. Pharm. Sci. Technol. 2014, 68 (1), 38–50.

   OpenUrlFREE Full Text
4. 4.↵
   1. Gefroh E.,
   2. Dehghani H.,
   3. McClure M.,
   4. Connell-Crowley L.,
   5. Vedantham G.

   Use of MMV as a Single Worst-Case Model Virus in Viral Filtration Validation Studies. PDA J. Pharm. Sci. Technol. 2014, 68 (3), 297–311.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Strauss D.,
   2. Schwartz A.,
   3. Hirotomi N.

   Avoiding the Pitfalls of Viral Clearance Experimental Design: Utilizing Representative Spiking Conditions. 249th American Chemical Society National Meeting, March 22–26, 2015, Denver, CO, BIOT Paper 124.
6. 6.↵
   1. Ferreira G.,
   2. Prentice J.,
   3. Rajarajan S.,
   4. Zhu M.,
   5. Dickson M.,
   6. Lutz H.,
   7. Robbins D.

   Effective Strategy for a Comprehensive QbD Characterization of Viresolve^® filter: A Collaboration between MedImmune and EMD Millipore. 249th American Chemical Society National Meeting, March 22–26, 2015, Denver, CO, BIOT Paper 416.
7. 7.↵
   1. Rayfield W.,
   2. Roush D.,
   3. Chmielowski R.,
   4. Tugcu N.,
   5. Barakat S.,
   6. Cheung J.

   Prediction of Viral Filtration Performance of Monoclonal Antibodies Based on Biophysical Properties of Feed. Biotechnol. Prog. 2015, 31 (3), 765–774.

   OpenUrl
8. 8.↵
   1. Willkommen H.,
   2. Blümel J.,
   3. Brorson K.,
   4. Chen D.,
   5. Chen Q.,
   6. Gröner A.,
   7. Kreil T. R.,
   8. Robertson J. S.,
   9. Ruffing M.,
   10. Ruiz S.

   Meeting Report—Workshop on Virus Removal by Filtration: Trends and New Developments. PDA J. Pharm. Sci. Technol. 2013, 67 (2), 98–104.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Wieser A.,
   2. Berting A.,
   3. Medek C.,
   4. Poelsler G.,
   5. Kreil T. R.

   The Evolution of Down-Scale Virus Filtration Equipment for Virus Clearance Studies. Biotechnol Bioeng. 2015, 112 (3), 633–637.

   OpenUrl
10. 10.↵
    1. Hongo-Hirasaki T.

    ptimization of Virus Removal Filtration Processes. PDA/FDA Virus and TSE Safety Conference 2015.
11. 11.↵
    1. Adan-Kubo O. J.

    Virus Behavior during Filtration Is Affected by Structure of Filter Membrane and Brownian Motion of Virus. PDA/FDA Virus and TSE Safety Conference 2014.
12. 12.↵
    1. Lute S.

    ; FDA. Virus Filtration Breakthrough Risks and Mitigation Strategies. PDA/FDA Virus and TSE Safety Conference 2014.
13. 13.↵
    1. Bolton G.,
    2. Cabatingan M.,
    3. Rubino M.,
    4. Lute S.,
    5. Brorson K.,
    6. Bailey M.

    Normal-Flow Virus Filtration: Detection and Assessment of the Endpoint in Bioprocessing. Biotechnol. Appl. Biochem. 2005, 42 (2), 133–142.

    OpenUrlPubMed
14. 14.↵
    1. Slocum A.,
    2. Burnham M.,
    3. Genest P.,
    4. Venkiteshwaran A.,
    5. Chen D.,
    6. Hughes J.

    Impact of Virus Preparation Quality on Parvovirus Filter Performance. Biotechnol. Bioeng. 2013, 110 (1), 229–239.

    OpenUrlPubMed
15. 15.↵
    1. Roush D.,
    2. Myrold A.,
    3. Burnham M.,
    4. Hughes J.

    Limits in Virus Filtration Capability? Impact of Virus Quality and Spike Level on Virus Removal with Xenotropic Murine Leukemia Virus. Biotechnol. Prog. 2015, 31 (1), 135–144.

    OpenUrl